TRAITEMENT DES MALADIES ASSOCIÉES À LA GLOBULINE SE LIANT AUX HORMONES SEXUELLES (SHBG) PAR INHIBITION DU PRODUIT DE TRANSCRIPTION ANTI-SENS NATUREL EN SHBG
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Sex Hormone Binding Globulin (SHBG), in particular, by targeting natural antisense polynucleotides of Sex Hormone Binding Globulin (SHBG). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of SHBG.